enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pseudodementia - Wikipedia

   en.wikipedia.org/wiki/Pseudodementia

   If effective medical treatment for depression is given, this can aid in the distinction between pseudodementia and dementia. Antidepressants have been found to assist in the elimination of cognitive dysfunction associated with depression, whereas cognitive dysfunction associated with true dementia continues along a steady gradient.

3. Dementia Doctors Share The Changes They Would Make ... - AOL

   www.aol.com/dementia-doctors-share-changes-today...

   Age is the biggest risk factor for developing dementia, according to the World Health Organization, but others such as genetics, early education, socioeconomic status, and gender all play a role.

4. Psychological therapies for dementia - Wikipedia

   en.wikipedia.org/wiki/Psychological_therapies...

   Design draft for a reality orientation board used to help people with dementia or in post-operative delirium. The aim of cognition-oriented treatments, which include reality orientation and cognitive retraining is the restoration of cognitive deficits. Reality orientation consists in the presentation of information about time, place or person ...

5. A Common Drug Could Lower Your Dementia Risk By 35 ... - AOL

   www.aol.com/common-drug-could-lower-dementia...

   Not only that, they had a 52 percent lower risk of vascular dementia, and a 39 percent lower risk of Alzheimer’s dementia. People who took SGLT-2 inhibitors for longer periods of time seemed to ...

6. Which cardiovascular drugs may help lower dementia risk? - AOL

   www.aol.com/cardiovascular-drugs-may-help-lower...

   Cardiovascular treatments and dementia risk: The takeaways. Overall, the data adds to understanding regarding cardiovascular disease drugs and how they may affect dementia risk.

7. Ergoloid - Wikipedia

   en.wikipedia.org/wiki/Ergoloid

   It has been used to treat dementia and age-related cognitive impairment (such as in Alzheimer disease), [1] as well as to aid in recovery after stroke.. A systematic review published in 1994 found little evidence to support the use of ergoloid mesylates, concluding only that potentially effective doses may be higher than those currently approved in dementia treatment.